Diamedix and Delta Biologicals’ suite of diagnostic tests: Fumouze Diagnostics to be exclusive distributor in France

IVAX Diagnostics, Inc. (AMEX: IVD), a fully integrated global in vitro diagnostics company, announced that Diamedix Corporation has signed a distribution agreement with Fumouze Diagnostics, a division of Sofibel S.A.S., of Paris, France, pursuant to which Fumouze Diagnostics will be the exclusive third party distributor of Diamedix Corporation and Delta Biologicals S.r.l.’s suite of diagnostic tests in France. Diamedix is a U.S. subsidiary of IVAX Diagnostics and Delta Biologicals is IVAX Diagnostics’ subsidiary located in Italy. The initial term of the distribution agreement is three years.

Fumouze Diagnostics has been a major participant in the diagnostics field for more than 40 years, and offers a broad range of products to its private and public laboratory clients. To support the sales efforts in France under this distribution agreement, Fumouze Diagnostics has agreed to hire a sales representative to sell Diamedix and Delta Biologicals’ products in collaboration with Fumouze Diagnostics’ existing direct sales force. Diamedix and Delta Biologicals have a combined suite of products that includes more than 200 diagnostics tests in the areas of infectious disease, autoimmune disease and allergies. Delta Biologicals also manufactures a line of instruments for use in clinical and hospital laboratories.

Charles Struby, Ph.D., Chief Executive Officer and President of IVAX Diagnostics, said, “As the international market for diagnostics increases in importance, one of our goals for 2010 is to increase our presence in key countries in Europe and South America. We expect that our distribution agreement with Fumouze Diagnostics will open the French market to Diamedix and Delta Biologicals’ suite of more than 200 diagnostic tests and will be a major step towards attaining our goal of expanding our product reach in Europe. We believe that partnering with Fumouze Diagnostics, a company with a well-established history of bringing important products to market, and a reputation for outstanding customer service, will provide us with a strong and well-established distribution network for our expanding suite of diagnostics products.”

Source IVAX Diagnostics, Inc.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
You might also like... ×
EKF launches STAT-Site WB β-ketone and glucose whole blood analyzer in the U.S.